You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Claims for Patent: 11,185,535

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,185,535

Title:	Amorphous kinase inhibitor formulations and methods of use thereof
Abstract:	Provided herein is an amorphous compound represented by Formula (I):and compositions thereof, which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFRα kinases, and oncogenic forms thereof.
Inventor(s):	Michael D. Kaufman, Scott Bone, Corey Bloom, Fred Jordan
Assignee:	Deciphera Pharmaceuticals LLC
Application Number:	US17/180,234
Patent Claims:	1. A pharmaceutically acceptable tablet for orally delivering 50 mg of a compound represented by Formula (I): comprising: an intragranular blend, wherein the intragranular blend comprises: (i) a solid dispersion having 50 mg of the compound wherein the compound is present in amorphous form and hydroxypropyl methyl cellulose acetate succinate; (ii) about 25-35% by weight microcrystalline cellulose based on the total amount of the tablet; (iii) about 25-35% by weight of lactose or a hydrate thereof based on the total amount of the tablet; (iv) about 5% by weight of crospovidone based on the total amount of the tablet; (v) about 0.5% by weight of silicon dioxide based on the total amount of the tablet; and (vi) about 0.5% by weight of magnesium stearate based on the total amount of the pharmaceutical tablet; and an extragranular blend, wherein the extragranular blend comprises (i) about 0.5% by weight of silicon dioxide based on the total amount of the tablet; and (ii) about 0.5% by weight of magnesium stearate based on the total amount of the of the tablet wherein the tablet disintegrates in less than 1 minute as tested using USP <701> for uncoated tablets.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.